Xtant Medical Holdings, Inc. (FRA:XMS)

Market Cap	69.76M -2.5%
Revenue (ttm)	113.43M +16.9%
Net Income	1.49M
EPS	0.01
Shares Out	n/a
PE Ratio	46.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.5050
Previous Close	0.5450
Day's Range	0.5050 - 0.5050
52-Week Range	0.3260 - 0.7750
Beta	n/a
RSI	34.89
Earnings Date	Mar 6, 2026

About Xtant Medical Holdings

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bon...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• CEO: Sean Browne
• Employees: 232
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XMS

Financial Performance

Financial numbers in USD